New Delhi: During the last 24 hours, till Saturday 6 June evening, a total of 4,611 COVID-19 patients have been cured in India.
This takes the total of patients cured of COVID-19 in India to 1,14,073 with a recovery rate of 48.20% amongst COVID-19 patients. Presently, there are 1,15,942 active cases and all are under active medical supervision.
ICMR has further ramped up the testing capacity for detecting the novel Coronavirus in infected persons. The number of government labs has been increased to 520 and private labs has been increased to 222 (A total of 742). A total of 1,37,938 samples were tested in the last 24 hours. The total number of samples tested till now is 45,24,317.
Voluntary rBCG Vaccine Trial in Kolkata
ICMR-National Institute of Cholera and Enteric Diseases (NICED), the premier research organisation under Union Ministry of Health and Family Welfare has urged the healthcare workers of Kolkata (doctors, nurses, paramedical staff), more than 18 years or less, who are involved in treating COVID-19 patients in the city, to participate voluntarily in a regulatory trial to evaluate the efficacy of Recombinant BCG VPM 1002 in minimising infection incidence and disease severity of COVID-19 among high risk subjects. The institute is going to initiate this Central Drugs Standard Control Organisation (CDSCO) approved trial titled ‘A Multicentre, Phase III, Double-Blind, Randomised, Placebo-controlled Study’. The study will be conducted by Dr Shanta Dutta, Director, ICMR-NICED at the institute itself at Beliaghata.
The main objective of the study is to determine the effectiveness of rBCG vaccine in reducing and disease severity of COVID-19 infection among the healthcare Workers engaged in managing active COVID-19 patients.
Contacts with COVID-19 cases living in the containment zones of the city may also undergo the test.